TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13 déc. 2024 16h05 HE
|
TELA Bio, Inc.
MALVERN, Pa., Dec. 13, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction...
TELA Bio to Participate in Piper Sandler’s 36th Annual Healthcare Conference
19 nov. 2024 16h05 HE
|
TELA Bio, Inc.
MALVERN, Pa., Nov. 19, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions,...
TELA Bio Reports Third Quarter 2024 Financial Results
07 nov. 2024 16h05 HE
|
TELA Bio, Inc.
MALVERN, Pa., Nov. 07, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions,...
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 nov. 2024 16h05 HE
|
TELA Bio, Inc.
MALVERN, Pa., Nov. 01, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction...
TELA Bio Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
24 oct. 2024 16h05 HE
|
TELA Bio, Inc.
MALVERN, Pa., Oct. 24, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction, today announced the...
TELA Bio Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
23 oct. 2024 08h07 HE
|
TELA Bio, Inc.
MALVERN, Pa., Oct. 23, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction, today announced the...
TELA Bio Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
22 oct. 2024 16h05 HE
|
TELA Bio, Inc.
MALVERN, Pa., Oct. 22, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction, today announced...
TELA Bio to Announce Third Quarter 2024 Financial Results
17 oct. 2024 16h05 HE
|
TELA Bio, Inc.
MALVERN, Pa., Oct. 17, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction...
TELA Bio Reports Second Quarter 2024 Financial Results and Reiterates Full Year 2024 Revenue Guidance
12 août 2024 16h05 HE
|
TELA Bio, Inc.
MALVERN, Pa., Aug. 12, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions today...
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09 août 2024 16h05 HE
|
TELA Bio, Inc.
MALVERN, Pa., Aug. 09, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction...